Connor Clark & Lunn Investment Management Ltd. Invests $212,000 in GoHealth, Inc. $GOCO

Connor Clark & Lunn Investment Management Ltd. bought a new position in GoHealth, Inc. (NASDAQ:GOCO) in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 17,279 shares of the company’s stock, valued at approximately $212,000. Connor Clark & Lunn Investment Management Ltd. owned approximately 0.08% of GoHealth as of its most recent filing with the SEC.

Other institutional investors have also recently made changes to their positions in the company. FNY Investment Advisers LLC bought a new position in shares of GoHealth in the 1st quarter worth approximately $31,000. Cubist Systematic Strategies LLC bought a new position in GoHealth during the 4th quarter valued at approximately $37,000. Wells Fargo & Company MN increased its position in GoHealth by 28.2% during the 4th quarter. Wells Fargo & Company MN now owns 2,760 shares of the company’s stock valued at $37,000 after buying an additional 607 shares in the last quarter. N.E.W. Advisory Services LLC bought a new position in GoHealth during the 1st quarter valued at approximately $45,000. Finally, Bank of America Corp DE increased its position in GoHealth by 22.8% during the 4th quarter. Bank of America Corp DE now owns 7,831 shares of the company’s stock valued at $105,000 after buying an additional 1,452 shares in the last quarter. Institutional investors own 24.21% of the company’s stock.

GoHealth Stock Performance

Shares of GOCO opened at $5.41 on Thursday. The business’s fifty day simple moving average is $5.83 and its two-hundred day simple moving average is $9.54. The company has a current ratio of 1.56, a quick ratio of 1.56 and a debt-to-equity ratio of 2.64. GoHealth, Inc. has a 12 month low of $5.01 and a 12 month high of $21.00. The company has a market cap of $128.43 million, a price-to-earnings ratio of -1.50 and a beta of 1.49.

GoHealth (NASDAQ:GOCO) last issued its earnings results on Thursday, August 7th. The company reported ($1.23) EPS for the quarter, beating the consensus estimate of ($2.60) by $1.37. GoHealth had a negative return on equity of 8.74% and a negative net margin of 3.21%.The business had revenue of $94.05 million for the quarter, compared to the consensus estimate of $119.76 million. Research analysts anticipate that GoHealth, Inc. will post -5.5 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

GOCO has been the subject of a number of analyst reports. Royal Bank Of Canada reaffirmed a “sector perform” rating and set a $18.00 price objective on shares of GoHealth in a research report on Monday, May 19th. Noble Financial reaffirmed an “outperform” rating on shares of GoHealth in a research report on Friday, August 8th. Finally, Wall Street Zen lowered GoHealth from a “hold” rating to a “sell” rating in a research report on Friday, July 18th. One analyst has rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, GoHealth has a consensus rating of “Moderate Buy” and an average target price of $18.00.

About GoHealth

GoHealth, Inc operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs.